BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31185010)

  • 1. ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology.
    Cao Y; Xu H; Zhu Y; Shi MJ; Wei L; Zhang J; Cheng S; Shi Y; Tong H; Kang L; Lu L; Luo H; Yang X; Bai X; Wang R; Ma Y; Wang Y; Wang Z; Zhong K; Zhao BQ; Fan W
    PLoS Biol; 2019 Jun; 17(6):e3000313. PubMed ID: 31185010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.
    Winkler EA; Nishida Y; Sagare AP; Rege SV; Bell RD; Perlmutter D; Sengillo JD; Hillman S; Kong P; Nelson AR; Sullivan JS; Zhao Z; Meiselman HJ; Wendy RB; Soto J; Abel ED; Makshanoff J; Zuniga E; De Vivo DC; Zlokovic BV
    Nat Neurosci; 2015 Apr; 18(4):521-530. PubMed ID: 25730668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
    Han BH; Zhou ML; Abousaleh F; Brendza RP; Dietrich HH; Koenigsknecht-Talboo J; Cirrito JR; Milner E; Holtzman DM; Zipfel GJ
    J Neurosci; 2008 Dec; 28(50):13542-50. PubMed ID: 19074028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains.
    Bian Z; Yamashita T; Shi X; Feng T; Yu H; Hu X; Hu X; Bian Y; Sun H; Tadokoro K; Takemoto M; Omote Y; Morihara R; Abe K
    Brain Res; 2021 Sep; 1767():147569. PubMed ID: 34197775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice.
    Merlini M; Meyer EP; Ulmann-Schuler A; Nitsch RM
    Acta Neuropathol; 2011 Sep; 122(3):293-311. PubMed ID: 21688176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction.
    Gireud-Goss M; Mack AF; McCullough LD; Urayama A
    Neuroscientist; 2021 Dec; 27(6):668-684. PubMed ID: 33238806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy.
    Gustafsson S; Gustavsson T; Roshanbin S; Hultqvist G; Hammarlund-Udenaes M; Sehlin D; Syvänen S
    Neuropharmacology; 2018 Dec; 143():1-9. PubMed ID: 30201212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
    Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
    Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
    Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer's disease-like APPPS1 mice.
    Wagner LK; Gilling KE; Schormann E; Kloetzel PM; Heppner FL; Krüger E; Prokop S
    Acta Neuropathol Commun; 2017 Jun; 5(1):52. PubMed ID: 28646899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
    Sagare AP; Bell RD; Zlokovic BV
    Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
    Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
    Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
    Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
    Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
    Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
    Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
    J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
    Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
    Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-β Formation.
    Goulay R; Mena Romo L; Hol EM; Dijkhuizen RM
    Transl Stroke Res; 2020 Aug; 11(4):601-614. PubMed ID: 31776837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.